Brett H. Simmons

796 total citations
9 papers, 488 citations indexed

About

Brett H. Simmons is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brett H. Simmons has authored 9 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brett H. Simmons's work include Cancer Research and Treatments (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Liver physiology and pathology (2 papers). Brett H. Simmons is often cited by papers focused on Cancer Research and Treatments (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Liver physiology and pathology (2 papers). Brett H. Simmons collaborates with scholars based in United States. Brett H. Simmons's co-authors include Farbod Shojaei, Joseph H. Lee, James G. Christensen, Anthony Wong, Albert Stewart, Junli Feng, Dana D. Hu‐Lowe, Patrick B. Lappin, Simon Bergqvist and Xiaolin Kang and has published in prestigious journals such as Cancer Research, Cancer Letters and Journal of Hematology & Oncology.

In The Last Decade

Brett H. Simmons

9 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett H. Simmons United States 8 257 201 151 124 78 9 488
Toshifumi Kameyama Japan 14 328 1.3× 247 1.2× 165 1.1× 129 1.0× 31 0.4× 27 688
Wendy Cooper United States 8 184 0.7× 162 0.8× 95 0.6× 87 0.7× 53 0.7× 10 393
Marissa S. Mattar United States 12 290 1.1× 313 1.6× 230 1.5× 175 1.4× 43 0.6× 22 666
Yulin L. Liu United States 9 254 1.0× 263 1.3× 220 1.5× 137 1.1× 42 0.5× 11 600
Florian Ewald Germany 16 492 1.9× 228 1.1× 71 0.5× 201 1.6× 88 1.1× 25 792
Anne‐Claire Voegeli France 15 305 1.2× 355 1.8× 462 3.1× 155 1.3× 83 1.1× 25 772
Kazuma Sakuraba Japan 18 549 2.1× 286 1.4× 113 0.7× 194 1.6× 103 1.3× 34 845
Carol Y. Tong Hong Kong 9 238 0.9× 298 1.5× 358 2.4× 166 1.3× 95 1.2× 12 712
Christine To Canada 9 391 1.5× 323 1.6× 173 1.1× 196 1.6× 116 1.5× 11 708
Margarita Reboredo Spain 13 206 0.8× 304 1.5× 156 1.0× 204 1.6× 46 0.6× 31 553

Countries citing papers authored by Brett H. Simmons

Since Specialization
Citations

This map shows the geographic impact of Brett H. Simmons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett H. Simmons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett H. Simmons more than expected).

Fields of papers citing papers by Brett H. Simmons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett H. Simmons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett H. Simmons. The network helps show where Brett H. Simmons may publish in the future.

Co-authorship network of co-authors of Brett H. Simmons

This figure shows the co-authorship network connecting the top 25 collaborators of Brett H. Simmons. A scholar is included among the top collaborators of Brett H. Simmons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett H. Simmons. Brett H. Simmons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kashyap, Manoj Kumar, Deepak Kumar, Brett H. Simmons, et al.. (2017). Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia. Journal of Hematology & Oncology. 10(1). 112–112. 49 indexed citations
2.
Zhang, Cathy C., Zhengming Yan, Anand Giddabasappa, et al.. (2014). Comparison of dynamic contrast‐enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF‐03084014 and sunitinib. Cancer Medicine. 3(3). 462–471. 17 indexed citations
3.
Majeti, Bharat K., Joseph H. Lee, Brett H. Simmons, & Farbod Shojaei. (2013). VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma. BMC Cancer. 13(1). 213–213. 17 indexed citations
4.
Giddabasappa, Anand, Li D, Peter Olson, et al.. (2013). Contrast agents for quantitative microCT of lung tumors in mice.. PubMed. 63(6). 482–90. 10 indexed citations
5.
Shojaei, Farbod, Nathan Scott, Xiaolin Kang, et al.. (2012). Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer. Journal of Experimental & Clinical Cancer Research. 31(1). 26–26. 53 indexed citations
6.
Shojaei, Farbod, Brett H. Simmons, Joseph H. Lee, Patrick B. Lappin, & James G. Christensen. (2012). HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasis. Cancer Letters. 320(1). 48–55. 50 indexed citations
7.
Simmons, Brett H., Joseph H. Lee, Anand Giddabasappa, et al.. (2012). Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in KrasG12D-LSL mice. Cancer Chemotherapy and Pharmacology. 70(2). 213–220. 19 indexed citations
8.
Shojaei, Farbod, Joseph H. Lee, Brett H. Simmons, et al.. (2010). HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors. Cancer Research. 70(24). 10090–10100. 267 indexed citations
9.
Humphries, Paul S., Simon Bailey, Thomas J. Carlson, et al.. (2006). Pyridine-3-propanoic acids: Discovery of dual PPARα/γ agonists as antidiabetic agents. Bioorganic & Medicinal Chemistry Letters. 16(23). 6120–6123. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshifumi Kameyama Breakdown of academic impact, for papers by Wendy Cooper Breakdown of academic impact, for papers by Marissa S. Mattar Breakdown of academic impact, for papers by Yulin L. Liu Breakdown of academic impact, for papers by Florian Ewald Breakdown of academic impact, for papers by Anne‐Claire Voegeli Breakdown of academic impact, for papers by Kazuma Sakuraba Breakdown of academic impact, for papers by Carol Y. Tong Breakdown of academic impact, for papers by Christine To Breakdown of academic impact, for papers by Margarita Reboredo
Rankless by CCL
2026